REGENERON
Live / Allowed — Second extension granted (statement of use) (as of 02 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98652297
- Mark type
- Word mark
- Filed
- 17 Jul 2024
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 010 — Medical apparatus: Medical apparatuses, namely, catheters, combination drug delivery devices sold empty, infusion apparatus for therapeutic purposes, infusion and injection devices for administering drugs, kits for drug delivery comprised of a syringe, needle, catheter, and a cap
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 03 Nov 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2026 — SOU EXTENSION 2 GRANTED
- 02 Nov 2026 — SOU EXTENSION 2 FILED
- 02 Nov 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2026 — SOU EXTENSION 1 GRANTED
- 20 Apr 2026 — SOU EXTENSION 1 FILED
- 20 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE